Is class I recommendation for aspirin use in CVD prevention too strong? - PACE-CME

Is class I recommendation for aspirin use in CVD prevention too strong

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Women in cardiology research
Women in cardiology research
ESC 2022
Women in cardiology research
- Biljana Parapid, MD, PhD
Understanding the effects of ARNI in acute MI
Understanding the effects of ARNI in acute MI
ESC 2022
Understanding the effects of ARNI in acute MI
- Otavio Berwanger, MD, PhD
Unexpected findings when comparing DOAC with VKA in rheumatic AF
Unexpected findings when comparing DOAC with VKA in rheumatic AF
ESC 2022
Unexpected findings when comparing DOAC with VKA in rheumatic AF
- Prof. Ganesan Karthikeyan, MD
Aspirin or P2Y12i monotherapy for secondary prevention in patients with CAD?
Aspirin or P2Y12i monotherapy for secondary prevention in patients with CAD?
ESC 2022
Aspirin or P2Y12i monotherapy for secondary prevention in patients with CAD?
- Prof. Marco Valgimigli, MD, PhD